Anaveon, a New Immuno-Oncology Company, Announces CHF 35 million Series A Financing by admin | Feb 26, 2019 | Press ReleasesAnaveon, an immuno-oncology company, today announced completion of a CHF 35 million Series A financing led by Syncona Ltd and joined by the Novartis Venture Fund.
